Niagen Bioscience, Inc.

NAGE Consumer Defensive Packaged Foods

Niagen Bioscience, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.4 million, up 29.9% from fiscal 2024.

Revenue
−20.0%
EPS
−124.7%
Free cash flow
−28.4%

Quarter to September 2026, against a year earlier

2.07 0.04 −1.90%
Market cap
$166.6M
P/E
16.5×
Fwd P/E
20.1×
Dividend yield
—
F-score
6/9
Altman Z
10.54
Beneish M
−1.55
Dividend safety
n/a

Niagen Bioscience, Inc. (NAGE) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Niagen Bioscience, Inc. (NAGE) trades at a P/E ratio of 16.5×. Over the past ten years it has ranged from 0.0× (September 2024) to 518× (November 2024); the current reading is higher than 85% of that period. That is above the Packaged Foods industry median of 13.1× and in line with the Consumer Defensive sector median of 16.6×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 27.7× (46.21%)
FY2024 51.4× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —
FY2016 0.0× —

Quarterly newest first

Period P/E ratio Change
Sep 2026 23.3× 46.22%
Jun 2026 16.0× (13.20%)
Mar 2026 18.4× (33.55%)
Dec 2025 27.7× (19.98%)
43 more quarters

Against its own ten years

Low 0.0× High 518×
Ten-year median 0.0×
Current reading's percentile 85

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on NAGE